Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 7 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Beam Therapeutics INC paid sponsored hires in similar roles1 certified filing for “Senior Director, Program Management” (Natural Sciences Managers) in MA: $280k–$280k, median $280k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 7 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Beam Therapeutics INC paid sponsored hires in similar roles
- 1 certified filing for “Senior Director, Program Management” (Natural Sciences Managers) in MA: $280k–$280k, median $280k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Company Overview:
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Position Overview:
Beam is seeking an experienced Director, Filing Excellence Program Manager to provide project leadership for major global regulatory submissions, including Biologics License Applications (BLAs), Marketing Authorization Applications (MAAs), and associated Health Authority review activities. Working closely with Regulatory Affairs and cross-functional leaders, this role will translate regulatory strategy into an integrated execution plan that aligns content development, data availability, submission readiness, and review-cycle activities.
This individual will drive the end-to-end submission operating model, establishing the critical path, governance, decision-making forums, risk management, and readiness processes required to deliver high-quality submissions on time. The Director will serve as a central point of integration across Regulatory, Clinical, Biostatistics, Data Management, CMC, Nonclinical, Safety, Quality, Medical Writing, Labeling, and Regulatory Operations.
The ideal candidate is an experienced regulatory project leader who combines deep submission execution experience with strong cross-functional leadership, operational judgment, and the ability to create clarity and drive decisions in complex, fast-moving environments.
Responsibilities:
• Drive integrated submission planning and execution by establishing and leading the end-to-end submission plan and critical path, including content development, data availability, review and approval cycles, publishing, submission, and Health Authority review.
• Translate regulatory strategy into an executable operating plan by partnering with Regulatory Affairs and functional leaders to define deliverables, ownership, milestones, decision points, dependencies, and readiness criteria across submission modules and workstreams.
• Lead cross-functional submission readiness across Regulatory, Clinical, Biostatistics, Data Management, CMC, Nonclinical, Safety, Quality, Medical Writing, Labeling, and Regulatory Operations, ensuring alignment of data, analyses, documents, and submission content.
• Drive critical submission milestones, including readiness for pre-submission Health Authority interactions, content completion, cross-functional reviews and approvals, quality-control activities, publishing handoffs, and final submission readiness assessments.
• Establish submission governance and decision-making forums, with clear decision rights, escalation pathways, risk management, and executive reporting that enable rapid issue resolution and informed leadership decisions.
• Provide clear visibility to submission readiness through fit-for-purpose dashboards, milestone tracking, risk and decision logs, and executive reporting focused on critical-path status, emerging risks, resource constraints, and decisions required.
• Lead rolling-submission planning and execution (when applicable) by defin
Apply on employer site ↗